Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
5.31 USD | +2.31% | +0.57% | +41.22% |
Kurzporträt
Mitarbeiterzahl: 83
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Joseph Todisco
CEO | Chief Executive Officer | 48 | 18.03.22 |
Mathew David
DFI | Director of Finance/CFO | 47 | 11.05.20 |
Tushar Mukherjee
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.22 |
General Counsel | - | 12.12. | |
Erin Mistry
PRN | Corporate Officer/Principal | 43 | 01.01.20 |
Frank Raffaele
PRN | Corporate Officer/Principal | - | 12.05.22 |
Donna Ucci
PRN | Corporate Officer/Principal | - | 12.05.22 |
Corporate Officer/Principal | 45 | 01.03.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Myron Kaplan
CHM | Chairman | 79 | 27.04.16 |
Steven Lefkowitz
DFI | Director of Finance/CFO | 68 | 15.08.11 |
Alan Dunton
BRD | Director/Board Member | 70 | 01.03.19 |
Janet Dillione
BRD | Director/Board Member | 65 | 06.08.15 |
Joseph Todisco
CEO | Chief Executive Officer | 48 | 18.03.22 |
Gregory Duncan
BRD | Director/Board Member | 59 | 02.11.20 |
Robert Stewart
BRD | Director/Board Member | 56 | 13.04.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 54 981 102 | 54 425 049 ( 98,99 %) | 0 | 98,99 % |
Aktie B | 0 | 181 622 | 0 | 0 |
Unternehmenskontakt
CorMedix, Inc.
300 Connell Drive Suite 4200
07922, Berkeley Heights
+908 517 9500
http://www.cormedix.comSektor
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+41.22% | 292 Mio. | |
+5.31% | 70.44 Mrd. | |
+10.97% | 8.94 Mrd. | |
-16.83% | 4.75 Mrd. | |
+43.48% | 4.5 Mrd. | |
+3.20% | 3.85 Mrd. | |
-21.36% | 2.34 Mrd. | |
-29.67% | 2.2 Mrd. | |
+8.38% | 1.96 Mrd. | |
+3.90% | 1.65 Mrd. |
- Börse
- Aktien
- A2PF3G Aktie
- Unternehmen CorMedix Inc.